PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables
- PMID: 1350788
- PMCID: PMC495304
- DOI: 10.1136/jcp.45.5.416
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables
Abstract
Aims: To investigate the expression of two cell cycle related antigens (proliferating cell nuclear antigen (PCNA) and Ki67 related antigen) in a series of breast cancers; and the possible correlations between the PCNA and Ki67 labelling indexes (PCNA-LI and Ki67-LI) and their associations with other biological and clinicopathological variables.
Methods: Ninety six ductal and 10 lobular carcinoma specimens were investigated. Samples were fixed in formalin and in Methacarnoy for localisation of PCNA. Ki67 was immunostained on frozen sections. The PCNA-LI and Ki67-LI were evaluated in relation to tumour size, mitotic count, histological grade, nodal state as well as receptor content and altered expression of the p53 gene.
Results: PCNA-LI did not correlate with Ki67-LI, nor was it associated with any other variable examined. A high KI67-LI (above the median value of 13.5) was associated with high grade and mitotic count, negative receptor content, and altered expression of the p53 gene, but not with other variables.
Conclusions: The PCNA-LI does not seem to be a substitute for the Ki67-LI in evaluating the growth fraction in breast cancer.
Similar articles
-
p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.Am J Clin Pathol. 1992 Oct;98(4):408-18. doi: 10.1093/ajcp/98.4.408. Am J Clin Pathol. 1992. PMID: 1357956
-
Expression of proliferating cell nuclear antigen, Ki-67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: an immunochemical study with clinical, pathobiological, and histologic correlations.Diagn Cytopathol. 1994;11(2):131-40. doi: 10.1002/dc.2840110206. Diagn Cytopathol. 1994. PMID: 7813360
-
p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.J Clin Pathol. 1993 Dec;46(12):1093-6. doi: 10.1136/jcp.46.12.1093. J Clin Pathol. 1993. PMID: 7904273 Free PMC article.
-
Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.Jpn J Clin Oncol. 1993 Feb;23(1):20-5. Jpn J Clin Oncol. 1993. PMID: 8096256
-
Immunohistochemical analysis of hormone receptors and proliferating cell nuclear antigen in aggressive angiomyxoma of the vulva.Int J Gynaecol Obstet. 1993 May;41(2):171-9. doi: 10.1016/0020-7292(93)90701-w. Int J Gynaecol Obstet. 1993. PMID: 8099033 Review.
Cited by
-
Regulation of gene expression in rats with spinal cord injury based on microarray data.Mol Med Rep. 2015 Aug;12(2):2465-72. doi: 10.3892/mmr.2015.3670. Epub 2015 Apr 23. Mol Med Rep. 2015. PMID: 25936407 Free PMC article.
-
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.Oncotarget. 2016 Nov 22;7(47):77777-77792. doi: 10.18632/oncotarget.12795. Oncotarget. 2016. PMID: 27780919 Free PMC article.
-
A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.Am J Pathol. 1993 Jan;142(1):3-9. Am J Pathol. 1993. PMID: 8093827 Free PMC article.
-
Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer.Eur Arch Otorhinolaryngol. 1994;251(2):91-4. doi: 10.1007/BF00179899. Eur Arch Otorhinolaryngol. 1994. PMID: 7517683
-
Morin augments anticarcinogenic and antiproliferative efficacy against 7,12-dimethylbenz(a)-anthracene induced experimental mammary carcinogenesis.Mol Cell Biochem. 2012 May;364(1-2):79-92. doi: 10.1007/s11010-011-1207-5. Epub 2012 Feb 19. Mol Cell Biochem. 2012. PMID: 22350814
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous